The study of an agent's or individual's decisions is known as decision theory. The official decision-making process concludes with evaluation. Evaluating the consequences may assist the decision-maker in learning lessons that will help her make better decisions in the future.
- Loss aversion is the correct answer because the general notion of the "loss-aversion" theory is that if an individual is provided with two equal alternatives, one of which is presented in terms of prospective profits and the other in terms of potential losses, the former option will be chosen.
- Loss aversion is a cognitive bias or psychological phenomenon that explains why the agony of losing is twice as powerful psychologically as the pleasure of winning.
Therefore, representativeness, cognitive bias, and overconfidence are not factors relative to an arbitrary decision distortion. So, Loss aversion is the correct response to the question.
For more information regarding arbitrary baseline, refer to the link:
brainly.com/question/11224360
Supplementary angles equal 180 degrees.
180-113= 67
m<2= 67
I hope this helps!
~cupcake
Answer:
well why do you think your cut out for it
Explanation:
be yourself why are u intrested
Answer:
The correct answer is letter "C": Strong form.
Explanation:
The Efficient Market Hypothesis (EMH) is the theory that beating the market is impossible because current stock prices reflect all the information investors need to trade the markets. Technical and fundamental analysis remain useless in trying to predict future price action.
The EMH could be classified as the <em>Weak, Strong, </em>and <em>Semi-Strong EMH</em>. The strong form of the EMH establishes that insider information and public information are already in the current stock price, then, there is no special data that could provide an advantage to an investor to take advantage of the market.
In such a case,<em> the strong form of the EMH is opposed to the idea given in the example since it is proposing insider information gives employees an advantage to make large profits before the information of trial drugs is spread among the public.</em>
